羧基麦芽糖铁注射液用于非透析慢性肾脏病贫血患者的有效性和安全性:一项真实世界研究

Efficacy and safety of ferric carboxymaltose injection in the treatment of anemia in patients with non-dialysis chronic kidney disease: a real-world study

:-
 
目的:初步探索羧基麦芽糖铁(FCM)治疗非透析慢性肾脏病(ND-CKD)贫血患者的有效性与安全性,为FCM在我国ND-CKD贫血患者中的临床应用提供参考。方法:本研究为单中心、前瞻性、单臂研究,纳入25例ND-CKD贫血患者,给予FCM 500 mg或1000 mg单次静脉输注,分别于基线和 FCM治疗的1周后、1月后采集患者外周血,检测血红蛋白、血清铁蛋白、转铁蛋白饱和度,同时观察、记录不良事件发生情况。结果:(1)患者经FCM单次输注后,1周后及1月后的血红蛋白、血清铁蛋白、转铁蛋白饱和度均显著升高(P<0.05)。与FCM治疗1周后相比,1月后的血红蛋白显著升高(P<0.05),血清铁蛋白、转铁蛋白饱和度均显著降低(P<0.05)。(2)2例患者发生低磷血症,1例患者出现过敏性皮疹,1例患者出现输注侧上肢酸胀不适。结论:FCM作为新型快速补铁制剂,可有效改善ND-CKD患者的贫血及铁代谢,短期安全性整体可控。
Objective: To preliminarily explore the efficacy and safety of ferric carboxymaltose (FCM) in the treatment of anemia in patients with non-dialysis chronic kidney disease (ND-CKD), and to provide a reference for the clinical application of FCM in Chinese ND-CKD patients with anemia. Methods: This was a single-center, prospective, single-arm study. A total of 25 ND-CKD patients with anemia were enrolled and received a single intravenous infusion of FCM at a dose of 500 mg or 1000 mg. Peripheral blood samples were collected from the patients at baseline, 1 week, and 1 month after FCM treatment to measure hemoglobin, serum ferritin, and transferrin saturation. Meanwhile, adverse events were observed and recorded. Results: (1) After a single infusion of FCM, the levels of hemoglobin, serum ferritin, and transferrin saturation were significantly increased at one week and one month post-treatment (P<0.05). Compared with the values at one week after FCM treatment, hemoglobin levels at one month were significantly higher (P<0.05), while serum ferritin and transferrin saturation levels were significantly lower (P<0.05). (2) Two patients developed hypophosphatemia, one patient experienced an allergic rash, and one patient reported soreness and discomfort in the upper limb on the infusion side. Conclusion: As a novel and rapid iron supplement preparation, FCM can effectively improve anemia and iron metabolism in patients with ND-CKD, with overall manageable short-term safety.
论著

基于“固肾泄浊”理法方药辨治慢性肾衰竭的应用

Prescription of chronic renal failure based on the theory of “reinforcing the kidney and reducing turbidity”

:293-298
 
       慢性肾衰竭(CRF)核心病机为脾肾两虚、湿浊瘀毒互结,形成“精亏-络损-浊毒”的恶性循环。文章基于“肾藏精泄浊”理论,系统阐释固肾泄浊法论治CRF的理论依据及临床实践经验。固肾泄浊法以“固肾培本,分消浊毒”为纲,通过填精固摄恢复脾肾气化枢纽,通络活血改善肾络瘀阻,并分消三焦湿浊、瘀浊、毒浊,打破“精微漏泄-浊毒蓄积—络脉损伤”病理过程。唐阁主任基于此创立固肾泄浊方,临床观察表明该方治疗CRF患者疗效确切。固肾泄浊方组方注重脾肾互根、寒温相济、升降相因,动态调整固肾与泄浊权重,契合CRF不同分期病机演变。固肾泄浊法融合藏象学说、络病理论及三焦气化论,以“补泻兼施、藏泄并调”实现标本同治,为CRF中医药治疗提供新思路。
       The core pathological mechanism of chronic renal failure(CRF)involves deficiency of the spleen and kidney,intertwined with dampness,turbidity,blood stasis and toxins,forming a vicious cycle of “essence deficiency-collateral damage-turbid toxin accumulation” Based on the theory of “The kidney stores essence and reduces turbidity”,this article systematically elucidates the theoretical foundation and clinical application of  reinforcing the kidney and  reducing turbidity method for treating CRF.This method,guided by the principles of “securing the kidney to strengthen the root,and resolving turbid toxins”,aims to replenish essence and consolidate the kidney to restore the pivotal qi transformation functions of the spleen and kidney,to unblock collaterals and circulate blood to ameliorate renal collateral stasis,to resolve damp-turbidity,stasis-turbidity,and toxin-turbidity from the Sanjiao.This strategy breaks the pathological progression of “leakage of essence-accumulation of turbid toxins-damage to collaterals”.Professor Tang Ge formulate this Reinforcing the Kidney and Reducing Turbidity Formula(固肾泄浊方,Gushen Xiezhuo Fang)based on this approach.Clinical observations confirmed its significant efficacy in CRF patients.The formula focuses on the interdependence of the spleen and kidney,balance of warm and cool properties,and harmony of ascending and descending actions.It dynamically adjusts the therapeutic focus between kidney-securing and turbidity-reducing to align with the evolving pathogenesis across different CRF stages.Integrating theories of visceral manifestation(Zangxiang),collateral disease,and Sanjiao qi transformation,reinforcing the kidney and  reducing turbidity method achieves simultaneous treatment of  root and branch through “simultaneous supplementation and drainage,concurrent storing and discharging”.This approach offers a novel perspective for the traditional Chinese medicine treatment of CRF.
论著

基于NHANES数据库中年人群血清同型半胱氨酸水平与肾功能下降的阈值效应分析

Threshold effect of serum homocysteine level on kidney function decline among middle-aged adults in America based on NHANES database

:1061-1068
 
目的 血清同型半胱氨酸(Hcy)水平与慢性肾脏病(CKD)的进展相关,但中年人群的非线性关联研究较少,本研究旨在寻找慢性肾脏病危险因素。方法 本研究基于NHANES 1996—2006年数据,纳入5 361例45~65岁参与者,以估算肾小球滤过率(eGFR)<60 mL/(min·1.73 m2)和尿白蛋白/肌酐比值(uACR)≥30 mg/g评估肾功能下降。结果 通过逻辑回归及平滑曲线拟合分析发现,Hcy每升高1 µmol/L,eGFR降低的风险增加8%(OR=1.08,95%CI:1.06~1.10),uACR升高的风险增加2%(OR=1.02,95%CI:1.00~1.04)。非线性分析显示,Hcy对eGFR的阈值效应拐点为13.4 µmol/L(拐点左侧OR=1.59,95%CI:1.49~1.70;右侧无显著关联)。亚组分析表明,性别、高血压、糖尿病等协变量无交互作用,然而,在敏感性分析中,糖尿病患者中Hcy与eGFR降低的关联更强(交互P=0.015 8)。结论 本研究提示,控制Hcy水平或可延缓美国中年人群(尤其是糖尿病患者)的肾功能衰退。
Objective Elevated serum homocysteine(Hcy)levels are linked to chronic kidney disease(CKD)progression,yet the nonlinear relationship in middle-aged populations remains underexplored.Methods This study analyzed data from 5 361 participants aged 45-65 years in the NHANES 1996-2006 cohort.Renal dysfunction was defined as an estimated glomerular filtration rate(eGFR)<60 mL/min/1.73 m2 and urinary albumin-to-creatinine ratio(uACR)≥30 mg/g.Results Logistic regression and smoothed curve fitting revealed that each 1 µmol/L increase in Hcy elevated the risk of reduced eGFR by 8%(OR=1.08,95% CI:1.06-1.10)and uACR by 2%(OR=1.02,95% CI:1.00-1.04).A nonlinear threshold effect was identified at 13.4 µmol/L,with a stronger association below this threshold(OR=1.59,95% CI:1.49-1.70)and no significant effect above it.Subgroup analyses showed no interactions with gender or hypertension,but a stronger Hcy-eGFR association was observed in diabetics(interaction P=0.0158).Conclusions These findings suggest that controlling Hcy levels may mitigate renal decline,particularly in diabetic populations,warranting further causal investigations.
专家综述

纳米材料在肾脏中的应用与清除机制

Application and clearance mechanism of nanomaterials in the kidney

:1-10
 
纳米材料作为一种新兴材料,在疾病诊断与治疗中拥有极大的应用潜力。为平衡纳米材料的生物活性和生物毒性之间的关系,清楚了解纳米材料在体内的清除机制和清除速率至关重要。其中,肾脏,作为人体重要的清除器官,直接影响纳米材料从血液清除到尿液的速率,进而影响其在生物体内的血液循环、肿瘤靶向效率和体内滞留等系列问题,最终影响其临床应用。基于近年来已报道的关于纳米材料与肾脏相互作用的诸多研究,本文系统介绍了肾脏结构、纳米材料在肾脏中的传输机制、理化性质对其肾脏清除效率的影响以及纳米材料在肾脏疾病诊疗中的应用。本文有望为精准纳米医学的发展以及纳米材料未来的临床转化起到促进作用。
Nanomaterials, as emerging materials, show great promise for the detection, diagnosis and treatment of diseases. Fully understanding their elimination pathway and clearance efficiency is important to better balance the bioactivity and biotoxicity of nanomaterials. Kidneys, as a major organ, play a key role in the clearance of nanomaterials from blood to urine. The clearance rate of nanomaterials in the kidneys directly affects their blood circulation, retention in the body and tumor targeting efficiency as well as final clinical applications. Based on current understanding of nano-bio interactions of nanomaterials in the kidneys, in this review, we introduced the kidney structure and elimination mechanism of nanomaterials in the kidneys. Then, how the physicochemical properties of nanomaterials affect their renal clearance efficiency are summarized. Finally, their applications in the kidney disease detection and treatment are presented. The basic understanding of nano-bio interactions of nanomaterials in the kidneys would promote the development of precise nanomedicine and their future clinical translation.
论著

推拿联合补肾祛瘀针刺法治疗慢性腰肌劳损恢复期患者的疗效及对表面肌电图的影响

Effect of massage combined with kidney tonifying and blood stasis removing acupuncture on chronic lumbar muscle strain convalescent patients and its influence on surface electromyography

:35-39
 
目的 探讨与分析推拿联合补肾祛瘀针刺法治疗慢性腰肌劳损恢复期患者对腰部疼痛及表面肌电图的影响。方法 选择2019年9月—2022年4月我院收治的72例慢性腰肌劳损恢复期患者为研究对象,根据随机1∶1数字表法,分为联合组与对照组各36例。对照组给予推拿治疗,联合组在此基础上,给予补肾祛瘀针刺法治疗,2组均治疗并观察4周,评价腰部疼痛及表面肌电图变化情况。结果 治疗后联合组与对照组的总有效率分别为97.2%和75%,联合组高于对照组(P<0.05);治疗前,2组患者的视觉类比疼痛评分法(VAPS)和下腰痛失能问卷(OPDG)评分比较差异无统计学意义,治疗后,2组患者的VAPS和OPDG评分均降低,且联合组低于对照组(P<0.05);2组治疗后的腰椎前屈力度都高于治疗前(P<0.05),且联合组更高(P<0.05);2组治疗后的表面肌电图神经根振幅和潜伏期均低于治疗前(P<0.05),且联合组更低(P<0.05)。联合组与对照组治疗后的血清5-HT含量均高于治疗前(P<0.05),联合组更高(P<0.05)。结论 推拿联合补肾祛瘀针刺法在慢性腰肌劳损恢复期患者中的应用具有良好的安全性,有效改善患者的腰椎功能,缓解患者疼痛,提高整体治疗效果,也能改善患者的表面肌电图状况,促进血清5-HT的释放。
Objective To explore and analyze the effects of massage combined with kidney tonifying and blood stasis removing acupuncture on lumbar pain and surface electromyography in patients with chronic lumbar muscle strain in the recovery period.Methods From September 2019 to April 2022, 72 cases of patients in the recovery period of chronic lumbar muscle strain treated in our hospital were selected as the research objects, and were divided into the combined group and the control group with 36 cases in each group by the random 1∶1 number table method.The control group were given massage therapy, and the combination group were given kidney tonifying and stasis removing acupuncture additionally.Results After treatment, the total effective rates of combined group and control group were 97.2% and 75%, respectively, and the combined group was significantly higher than the control group(P<0.05).Before treatment, there was no significant difference in the visual analogue pain scale(VAPS)and Oswestry low pain & disability questionnaire(OPDG)scores between the two groups, but after treatment, the scores of the two groups were significantly decreased, and the combined group was significantly lower than the control group(P<0.05).The lumbar flexion intensity after treatment was significantly higher in both groups than before treatment(P<0.05), and higher in combination group(P<0.05).The amplitude and latency of surface electromyogram nerve roots after treatment were significantly lower in both groups than before treatment(P<0.05), and even lower in combination group(P<0.05).The serum 5-HT content in combination group and control group after treatment was significantly higher than that before treatment(P<0.05), and that in combination group was higher(P<0.05).Conclusions The application of massage combined with kidney tonifying and blood stasis removing acupuncture in patients recovering from chronic lumbar muscle strain has good safety, which can improve the lumbar function of patients, relieve the pain of patients, improve the overall therapeutic effect, improve the surface electromyography of patients and promote the release of serum 5-HT.
论著

中药熏蒸配合穴位按摩的健康管理对稳定期肺肾气虚型慢阻肺的疗效

Efficacy of traditional Chinese medicine fumigation combined with acupoint massage on stable COPD with lung-kidney deficiency

:70-75
 
目的 探讨基于中药熏蒸配合穴位按摩的健康管理对稳定期肺肾气虚型慢阻肺的疗效。方法 选取2020年1月—2021年1月在我院接受治疗的稳定期肺肾气虚型慢阻肺患者120例为研究对象,随机分为对照组和干预组。对照组采用西医常规干预,干预组在此基础上实施为期1年的中药熏蒸配合穴位按摩的健康管理,比较干预前后2组患者肺功能、血氧指标以及生活质量的差异。结果 干预前,2组患者第1秒用力肺活量(FEV1)、第1秒用力肺活量占预计值百分比(FEV1%)、用力肺活量(FVC)、第1秒用力肺活量占用力肺活量的比值(FEV1/FVC%)等指标比较差异无统计学意义(P>0.05),干预后,2组患者的FEV1、FEV1%、FVC、FEV1/FVC%明显上升,且干预组患者优于对照组(P<0.05);实施相关干预前,干预组和对照组患者的血氧指标比较差异无统计学意义(P>0.05),干预后,2组患者的PaO2、和SpO2上升,PaCO2下降,且干预组的变化幅度大于对照组(P<0.05);干预前2组患者在圣乔治问卷(SGRQ)生活质量评分比较差异无统计学意义(P>0.05),干预后2组患者的SGRQ生活质量评分降低,且干预组患者的SGRQ生活质量指标评分更低(P<0.05)。结论 中药熏蒸配合穴位按摩应用于稳定期肺肾气虚型慢阻肺患者中,能够提高患者的肺功能,改善血氧指标,提高患者的生活质量。
Objective To explore the effect of health management based on traditional Chinese medicine fumigation combined with acupoint massage on stable chronic obstructive pulmonary disease(COPD)with lung-kidney deficiency.Methods A total of 120 patients with stable COPD and lung-kidney deficiency who received treatment in our hospital from January 2020 to January 2021 were selected as the study objects and randomly divided into control group and intervention group.The control group received conventional Western medicine intervention,and the intervention group received 1-year traditional Chinese medicine fumigation combined with acupoint massage on the basis of Western management.The differences of lung function,blood oxygen index and quality of life between the two groups were compared before and after intervention.Results Before intervention,there were no significant differences in forced expiratory volume in one second(FEV1),the first second forced vital capacity percentage of expected value(FEV1%),forced vital capacity(FVC),the ratio of the first second forced vital capacity of forced vital capacity(FEV1/FVC%)between the two groups(P>0.05),but after intervention,the FEV1,FEV1%,FVC,FEV1/FVC% of the two groups increased significantly,and those in the intervention group were better(P<0.05).Before the implementation of relevant intervention,there was no difference in blood oxygen index between the two groups(P>0.05).After the intervention,PaO2 and SpO2 of the two groups were significantly increased,while PaCO2 was significantly decreased,and the change in the intervention group was significantly greater(P<0.05).Before intervention,there were no significant differences in the quality of life scores of St George’s Respiratory Questionnaire(SGRQ)between the two groups(P>0.05).After intervention,the scores of SGRQ of the two groups were significantly decreased,and the scores of the intervention group were significantly lower(P<0.05).Conclusions Traditional Chinese medicine fumigation combined with acupoint massage can significantly improve lung function,blood oxygen index and life quality of stable COPD patients with lung-kidney deficiency.
专家综述

纳米载体药物用于缓解慢性肾脏病纤维化的研究进展

Recent advances in nanomedicines for alleviating chronic kidney disease fibrosis

:1-10
 
慢性肾脏病是一类具有高发病率、高死亡率的慢性疾病群。临床上一般采用血液透析和肾脏移植治疗终末期的慢性肾脏病。研究表明,小分子药物或核酸类药物在慢性肾脏病治疗中极具潜力,但是缺乏特异性导致肾脏纤维化治疗效果有限,亟需开发新的治疗策略。纳米载体因具有良好的理化性质,被广泛应用于生物医学领域。本文综述了近年来纳米载体递送小分子或核酸类药物在慢性肾脏病中的研究进展。
Chronic kidney disease (CKD) is a series of chronic disease groups associated with high morbidity and mortality. Hemodialysis and kidney transplantation are the only choices for end-stage renal disease. According to the literature report, it is shown that small molecule and nucleic acid drugs have great potential in CKD treatments with an unsatisfied therapeutic efficacy because of the lack of specific targeting. Thus, it is necessary to develop a new strategy. Nanocarriers have been widely used in biomedical fields due to their excellent physical and chemical properties. In this review, we have summarized the recent advances in applying functional nanocarriers to deliver the small molecules and nucleic acid drugs in the treatment of CKD.
论著

雷火灸治疗小儿下元虚寒型遗尿症30例

30 cases of kidney deficiency-cold syndrome enuresis children by thunder-fire moxibustion

:75-78
 
目的 探讨雷火灸对于小儿下元虚寒型遗尿症的临床疗效。方法 采用回顾性分析,将60例遗尿症患儿随机分为治疗组和对照组各30例,对照组给予基础治疗(包括调整作息饮食、膀胱功能锻炼、反射训练等),治疗组则在基础治疗外给予雷火灸温灸小腹部及温阳补肾的相应穴位,两组均连续治疗3周。比较两组治疗前后每周遗尿天数、每天遗尿次数、每天的睡眠深度及中医症候积分变化,观察两组临床疗效及6个月后的复发率。结果 治疗组使用雷火灸治疗小儿遗尿症的总有效率96.67%高于对照组的总有效率76.67%,治疗组中医症候积分减少优于对照组,治疗后6个月治疗组的复发率为10.34%,少于对照组,差异均有统计学意义(P<0.05)。结论 雷火灸能有效减少下元虚寒型遗尿症患儿的遗尿次数,疗效显著,值得临床推广应用。
Objective To investigate the clinical efficacy of treating kidney deficiency-cold syndrome enuresis children with thunder-fire moxibustion. Methods 60 cases were randomly divided into a control group of 30 cases and a treatment group of 30 cases. Patients in the control group were treated with basic treatment (including adjusting diet, bladder function exercise, reflex training and so on); while patients in the treatment group were treated with thunder-fire moxibustion,three weeks for treatment. The research was aimed at assessing the clinical effect of the two groups,observing the number of enuresis days per week, the number of enuresis times per day,the sleep depth per day and the change of TCM symptom score, and recording the recurrence rate after 6 months of treatment. Results The clinical efficacy of treatment group was better than that of the control group,and the efficiency was 96.67%,which was higher than that of the control group 76.67%,and the TCM symptom score of the treatment group decreased than that of the control group, both of the differences were statistically significant (P< 0.05). The recurrence rates at 6 months after treatment was 10.34% respectively,which were lower than those in the control group(P<0.05). Conclusion The therapy has good effect,it can reduce the number of enuresis times and has low recurrence.
论著

微通道联合负压吸引行经皮肾镜取石术治疗鹿角形肾结石的效果

Effect of percutaneous nephrolithotomyusing micro-channel combined with vacuum suction for treatment of staghorn kidney stones

:58-60
 
目的 探讨持续负压吸引在微通道经皮肾镜取石术治疗鹿角形肾结石的临床效果。方法 选取2016年1月—2017年12月在我院确诊鹿角形肾结石并行经皮肾镜取石术治疗的病例138例;根据通道大小、有无负压吸引装置分为观察组和对照组,其中观察组66例,采用20F微通道联合持续负压吸引,对照组72例,采用22F标准通道,无负压吸引。比较两组的术中生命体征变化、肾盂内压力以及术后发热的发生率。结果 观察组在术中血压和心率等生命体征变化、肾盂内压力以及术后发热的发生率均低于对照组,差异有统计学意义(P<0.05)。结论 微通道联合负压吸引行经皮肾镜取石术治疗鹿角形肾结石可以有效降低肾盂内压力,有效维持生命体征的稳定,减少术后发热的发生率,提高手术安全性。
Objective To explore the clinical effect of percutaneous nephrolithotomy for treatment of staghorn kidney stonesusingmicro-channel combined with vacuum suction. Methods A total of 138 patientsofstaghorn kidney stones with PCNL in our hospital from January 2016 to December 2017 were included and divided into experimental group and control group according to the size of the channel and the vacuum suction device. Y-type minimally invasive dilatation drainage kit of 20F micro-channelandvacuum suctionwere used in experimental group within 66 patients.A standard channel (22F diameter) without vacuum suction was used in control group within 72 patients. The changes in vital signs, intrapelvic pressureand incidence of postoperative fever were compared between experimental and control groups. Results The vital signs variety of blood pressure and heart rate, intrapelvic pressure and incidence of postoperative fever in experimental group were lower than those in control group(P<0.05). Conclusion Micro-channel combined with vacuum suctioninpercutaneous nephrolithotomy for treatment of staghorn kidney stones could effectively maintenance of stable vital signs, reduce intrapelvic pressure and the incidence ofpostoperative fever, and improve the safety of surgery.
临床诊疗

隔姜灸神厥穴并口服黄芪汤治疗脓毒症急性肾损伤的效果分析

Effects of ginger moxibustion on Shenque acupoint combined oral Astragalus membranaceus decotion in treatment of pyohemia acute kidney injury

:90-92
 
目的 通过观察隔姜灸神厥穴并同时口服黄芪汤治疗脓毒症急性肾损伤患者的效果分析,初步探讨该方法能否改善患者的APACHEⅡ评分,入住重症监护病房的时间有没有缩短,14天内死亡率有否差异。方法 以2014年1月—2015年8月于我院确诊的脓毒症急性肾损伤患者为研究对象,观察常规治疗(对照组)及常规治疗基础上给予隔姜灸神厥穴同时口服黄芪汤治疗(治疗组)对脓毒症急性肾损伤患者危重情况的影响。结果 治疗组患者的危重指标(APACHEⅡ评分)明显改善,患者治疗5天后组间比较差异有统计学意义(P<0.05);两组患者入住重症监护病房的时间比较,患者治疗第四周χ2=4.5241,P=0.0334,差异有统计学意义(P<0.05);14天死亡率差异无统计学意义(P>0.05)。结论 隔姜灸神厥穴同时口服黄芪汤治疗能有效改善脓毒症急性肾损伤患者的APACHEⅡ评分,入住重症监护病房的时间减少。
出版者信息








《广州医药》公众号